ILMN

192.8203.90%
SB

Steven Barnard

Chief Technology Officer

Dr. Steven Barnard, also known as Steve, Ph. D. is Chief Technology Officer of Illumina, Inc. from August 10, 2023. Dr. Barnard joined Illumina in 1998 as the company's first scientist and fourth employee, holding a variety of leadership positions within Illumina's R&D organization throughout his distinguished 25-year tenure. Through critical roles in research and technology development, Barnard contributed significantly to maturing Illumina's foundational science technologies including synthetic chemistry, protein engineering, surface science, assay research and nanofabrication. Dr. Barnard joined the Illumina, Inc. in 1998. He holds more than 100 patents globally and has been published in diverse, scientific journals, such as Analytical Chemistry, Nature, Science and Genome Research, to name a few. As Vice President and Head of Global Advanced Science, Dr. Barnard played an integral role in advancing Illumina's products, including the launch of the revolutionary NovaSeq X series. His profound understanding of Illumina's core technologies will allow him to step into this role and continue to improve R&D productivity and efficiency, as well as drive shareholder value. Barnard earned his Ph. D. in chemistry from Tufts University.

公司職務